A new cellular mechanism has been identified for modulating blood vessel permeability, which could have a significant impact on the treatment of cancerous tumours. Nitrosylation of beta-catenin protein by nitric oxide increases vascular permeability, potentially leading to the blockage of tumour growth.
Researchers at the IRCM discovered a way to counteract HIV-1's interference with Tetherin, a host protein that prevents viral transmission. The Vpu protein neutralizes Tetherin, allowing HIV-1 to spread and infect cells more easily. This finding could lead to the development of new strategies to combat HIV-1.
A team of researchers mapped the fragile sites of the yeast Saccharomyces cerevisiae genome, revealing a key mechanism in DNA repair. Inactive genes are wrapped more tightly than active ones, making them vulnerable to damage.
A study led by Dr. Tarik Möröy discovered a link between a gene variant and acute myeloid leukemia (AML), a subtype of blood cancer. The GFI136N variant is associated with a 60% higher risk of developing AML, making it a potential biomarker for evaluating prognosis in patients.
Researchers at the Institut de recherches cliniques de Montréal have identified a new molecular pathway required for the guidance of retinal axons within the optic chiasm. This guidance relies on the Boc receptor, which could lead to therapies stimulating axonal growth after injury or in neurodegenerative disorders.
A Canada-wide technology platform will map the human interactome, providing Canadian researchers with state-of-the-art equipment and integrated infrastructure. The project, led by Dr. Benoit Coulombe, aims to elucidate dynamic organization of proteins and molecules, potentially leading to better disease treatments.
Researchers have identified a crucial molecular pathway required for the formation of brain neural circuits. This breakthrough has significant implications for understanding how axons reach their targets, paving the way for new therapies to treat spinal cord injuries, neurodevelopmental disorders, and neurodegenerative diseases.
A Montreal-based research team has identified a new mechanism controlling NK cell activity, which could improve the treatment of cancers and infectious diseases. The team's breakthrough discovery reveals that the CRACC molecule enhances NK cell killer function.
Researchers have discovered a new mechanism that regulates the production of type I interferon, an important protein for clearing viral infections. This mechanism involves a protein-protein interaction between surface receptors on plasmacytoid dendritic cells and class I major histocompatibility complex molecules.
Researchers discovered that nerves connecting to flexor muscles are guided by a protein family called ephrin-B, which is closely related to the previously identified ephrin-A protein. This finding provides insights into how nerves form and could lead to new strategies for treating disorders such as epilepsy and mental retardation.
A study by Dr. Nabil G. Seidah's team reveals that annexin A2 can inhibit PCSK9's degradation of the LDLR receptor, leading to lower bad cholesterol levels. This discovery paves the way for a new drug to target cardiovascular diseases.
Scientists at the Institut de recherches cliniques de Montreal have discovered a novel mechanism regulating neural stem cell development in the retina. The Ikaros gene plays a crucial role in conferring early temporal competence to retinal progenitor cells, enabling them to generate specific cell types at different stages of development.
A study analyzing media coverage of the Schiavo case found that most articles contained medical inaccuracies and false hopes about her recovery. The researchers emphasize the importance of accurate information in end-of-life decision-making, which was challenged by relatives and public opinion during this high-profile controversy.
A research team led by Dr. Benoit Coulombe has developed a powerful proteomics approach to infer putative functions of previously uncharacterized proteins by identifying their interaction partners. The study reveals an intricate network of protein interactions that connect together 436 different proteins.
Montréal researchers have identified a novel cellular protein complex targeted by HIV-1 Vpr to stop infected cell division. This discovery may lead to the development of a new class of drugs to combat HIV.
A new study has shed light on the mechanisms controlling myelin formation, a process crucial for efficient nerve communication. Researchers found that Par-3 acts as a molecular scaffold to organize key proteins essential for myelination.
A key gene, Boc, has been identified as crucial for brain neural circuit formation and axon guidance in the nervous system. This discovery could lead to novel strategies for treating neurodegenerative diseases such as Alzheimer's and Parkinson's, and spinal cord injuries.
A genetic study by Dr. Marie Kmita and her colleagues reveals how Hox genes control limb formation and generate asymmetry in arms and legs. The sequential activation of these genes sets up the architecture of limbs, triggering the activation of a 'polarizing' gene called Sonic Hedgehog.
A Montréal research group identified two essential components of negative feedback control in hormone regulation, which are deficient in about half of pituitary tumors from Cushing disease patients. This finding provides a molecular explanation for hormone resistance and may lead to better management of the condition.
Researchers at IRCM discover EAT-2 suppresses NK cell activity, boosting killer function to combat cancers and infections. Medications inhibiting EAT-2 may improve treatment effectiveness for cancers and communicable diseases.
Dr. Veillette's team identified a basic mechanism controlling antibody production in B lymphocytes, which are hyperactive in autoimmune diseases. This breakthrough provides new therapeutic targets for reducing attacks on organs like the pancreas and kidneys.